The global market for self-expanding peripheral vascular stents is expected to grow at a significant CAGR due to high incidence and increase diagnosis rate of peripheral vascular disease. Increasing incidence of cardiac disorders, lifestyle changes and rise in smoking population are the factors which are anticipated to boost the growth of global self-expanding vascular stents market. Howerver, high cost is anticipated to remain the major restraint for the growth of global self-expanding peripheral vascular stents market.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/11404
Self-expanding stents can have advantage in longer occlusive lesions, where percutaneous transluminal angioplasty and balloon-expandable stents are associated with higher rates of re-stenosis and failure. The adoption rate of nitinol stents is high as compared to that of stainless steel stents and is estimated to be the fastest growing segment.
To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/11404
Geographically, global self-expanding peripheral vascular stents market is segmented into five regions viz. North America, Latin America, Europe, Asia Pacific and Middle East & Africa. North America is expected to lead the global self-expanding peripheral vascular stents market owing to comparatively high prevalence of the peripheral vascular diseases in the region. The developing nations in Asia Pacific, Middle East and Africa are expected to hold huge potential for growth in the global self-expanding peripheral vascular stents market, due to adoption of new technology and development in healthcare infrastructure
Buy Now: You can now buy a single user license of the report @ http://www.persistencemarketresearch.com/checkout/11404
Some of the key market players in the global self-expanding peripheral vascular stents market are MicroVention, Inc., B. Braun Melsungen AG, Abbott Laboratories, Biotronic NeuroNetwork, LLC, Medtronic, Alvimedica, Vascular Solutions, Inc. Meril Life Sciences Pvt. Ltd., Bard Peripheral